Benzinga | Nov 5, 2021 09:32AM EDT

Anika Therapeutics Q3 Adj. EPS $0.05 Beats $(0.21) Estimate, Sales $39.54M Beat $36.32M Estimate

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.21) by 123.81 percent. This is unchanged from the same period last year. The company reported quarterly sales of $39.54 million which beat the analyst consensus estimate of $36.32 million by 8.85 percent. This is a 24.74 percent increase over sales of $31.69 million the same period last year.